Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353405 · ClinicalTrials.gov registry record · Phase 3
HIV and STD Prevention for High-Risk, Inner-City, African American Youth
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,650
- Enrollment target
NCT00353405: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT00353405 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,650 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00353405, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,650 participants
- Enrollment target
Study Summary
This study will evaluate the joint and separate effectiveness of two HIV/STD prevention programs in providing protection against acquiring STDs and maintaining safer sex behavior.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Social Skills Training
- BEHAVIORAL Mass media
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,650 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
What the finished NCT00353405 record still lists
NCT00353405 is an interventional study that assigns participants to a tested intervention. Its 1,650 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT00353405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00353405 about?
NCT00353405 is a clinical study titled "HIV and STD Prevention for High-Risk, Inner-City, African American Youth". This study will evaluate the joint and separate effectiveness of two HIV/STD prevention programs in providing protection against acquiring STDs and maintaining safer sex behavior.
What is the current status of trial NCT00353405?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,650 participants. The study started on 2006-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00353405?
The interventions under investigation include: Control (BEHAVIORAL), Social Skills Training (BEHAVIORAL), Mass media (BEHAVIORAL).
Who is sponsoring clinical trial NCT00353405?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00353405's enrollment target sits among peer trials
1,650 139th of 2000 higher than 1,861 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia